Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2019 to Jul 2024
At Pittcon 2006, Bruker Daltonics today announces its
new R-series of convenient refrigerated magnets for its apex(R) line
of hybrid Fourier Transform mass spectrometers (Q-q-FTMS). Through a
joint development between Bruker Daltonics and the Bruker BioSpin
group, the R-series magnets incorporate innovative cryostats equipped
with cryocooler refrigeration units that replace the conventional
liquid nitrogen reservoir. This results in FTMS magnets that do not
require liquid nitrogen and require liquid helium only once a year.
R-series magnets are available at 7 Tesla (T), 9.4T and 12T field
strengths.
The new R-series greatly reduces the annual cost of cryogens for
FTMS magnets. Another advantage for mass spectrometrists is the
convenience of only having to schedule magnet maintenance once a year,
whereas traditional FTMS magnets require frequent liquid Nitrogen
fills, and periodic liquid Helium fills. The absence of the
conventional liquid nitrogen dewar in the R-Series also means that the
magnets are smaller, particularly at high field. Additional benefits
include a liquid helium reservoir that provides a suitable buffer in
the event of a power outage, allowing R-series magnets to stay at
field without power for an entire week.
Dr. Jeffrey Agar, Assistant Professor of Chemistry at Brandeis
University, explains: "Our laboratory studies protein modifications
that occur during neurodegeneration, and tries to understand their
role in disease progression. We are also studying the role of protein
modifications in memory processes, which can involve subtle
conformational changes. We use the high-resolution Bruker Daltonics
apex-Qe (Q-q-FTMS), equipped with the new refrigerated,
low-maintenance 9.4 Tesla magnet. We are particularly pleased with the
performance of this new refrigerated magnet from Bruker as it is
eco-friendly and improves our research efficiency significantly."
Pittcon 2006, the 57th Pittsburgh Conference and Exposition on
Analytical Chemistry and Applied Spectroscopy, will be held March
13-16 in Orlando, Florida in the Orange County Convention Center.
Bruker Daltonics will exhibit at booth #3155.
ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)
Bruker BioSciences Corporation, headquartered in Billerica,
Massachusetts, is the publicly traded parent company of Bruker
Daltonics Inc. and Bruker AXS Inc. Bruker Daltonics is a leading
developer and provider of innovative life science tools based on mass
spectrometry. Bruker AXS is a leading developer and provider of life
science, materials research and industrial X-ray analysis tools. For
more information about Bruker BioSciences Corporation, please visit
www.bruker-biosciences.com
CAUTIONARY STATEMENT
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking statements as
that term is defined in the Private Securities Litigation Reform Act
of 1995. Any forward-looking statements contained herein are based on
current expectations, but are subject to a number of risks and
uncertainties. The factors that could cause actual future results to
differ materially from current expectations include, but are not
limited to, risks and uncertainties relating to the companies'
reorganization strategies, integration risks, failure of conditions,
technological approaches, product development, market acceptance, cost
and pricing of the companies' products, changes in governmental
regulations, capital spending and government funding policies, FDA and
other regulatory approvals to the extent applicable, competition, the
intellectual property of others, patent protection and litigation.
These and other factors are identified and described in more detail in
our filings with the SEC, including, without limitation, our
respective annual reports on Form 10-K, our most recent quarterly
reports on Form 10-Q, and our current reports on Form 8-K. We disclaim
any intent or obligation to update these forward-looking statements.